Mealey's (November 2, 2020, 12:55 PM EST) -- WASHINGTON, D.C. — In its Nov. 2 orders list, the U.S. Supreme Court turned away a request by a brand-name drug maker for review of a divided 2019 Federal Circuit U.S. Court of Appeals affirmance that a disputed patent is indefinite (HZNP Finance Limited, et al. v. Actavis Laboratories UT Inc., No. 20-88, U.S. Sup.)....